Abstract
People who consume a diet rich in fruit and vegetables have lower risks of cancer, cardiovascular disease and all-cause mortality. Many prospective cohort studies have reported inverse associations between dietary intake or blood levels of beta-carotene and risks of cancer. Several large-scale trials were set up to assess whether beta-carotene supplementation might reduce the risk of cancer. Subsequently, evidence emerged from basic research which indicated that oxidative modification of low-density lipoprotein cholesterol increases its atherogenicity. The evidence from basic research, and epidemiological evidence for a possible protective effect of antioxidant vitamins for cardiovascular disease was strongest for vitamin E. More recently, further trials were set up to examine if supplementation with anti-oxidant vitamins might also reduce the risk of cardiovascular disease. This review summarises the available randomised evidence from published trials of beta-carotene supplementation involving 70,000 people from 3 large-scale trials in healthy populations and on vitamin E supplementation involving 29,000 patients at high-risk of cardiovascular disease from 5 large-scale trials. The results of these trials have been disappointing and failed to confirm any protective effect of these vitamins for either cancer or for cardiovascular disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Doll R, Peto R. The Causes of Cancer. Oxford: Oxford University Press, 1981.
Peto R, Doll R, Buckley JD, Sporn MB. Can dietary betacarotene materially reduce human cancer rates? Nature 1981;290:201–208.
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum J. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915–924.
Jialal I, Norkus EP, Cristol L, Grundy SM. Beta-carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1991;1086:34–38.
Steinberg D. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992;85:2337–2344.
Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. Arteriorscler Thromb 1993;13:590–600.
Steinberg D. Clinical trial of antioxidants in atherosclerosis: Are we doing the right thing? Lancet 1995;346:36–38.
Stamfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl JMed 1993;328:1444–1449.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC.VitaminEconsumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450–1456.
Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180–1190.
Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum, selenium, vitamin antioxidants and cardiovascular mortality: A 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462–468.
Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226–231.
Riemersma RA, Wood DA, MacIntyre CC, Elton RA, Gey KF, Oliver MR. Risk of angina pectoris and plasma concentrations of vitamin A, C, and E and carotene. Lancet 1991;337:1–5.
The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029–1035.
Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–1155.
Hennekens C, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl Med J 1996;334:1145–1149.
Stephens NG, Parsons A, Scholfield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study. Lancet 1996;347:781–786.
Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997;349:1715–1720.
GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSIPrevenzione trial. Lancet 1999;354:447–455.
Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Lancet 2002;357:89–95.
The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000;342:154–160.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Clarke, R., Armitage, J. Antioxidant Vitamins and Risk of Cardiovascular Disease. Review of Large-Scale Randomised Trials. Cardiovasc Drugs Ther 16, 411–415 (2002). https://doi.org/10.1023/A:1022134418372
Issue Date:
DOI: https://doi.org/10.1023/A:1022134418372